This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Intracerebral hemorrhage (ICH) occurs in 25 to 50% of cases of cerebral venous thrombosis (CVT).1,2⇓ Although there is increasing evidence that treatment with heparin remains safe and is appropriate in patients with hemorrhagic venous infarction,1,2⇓ some uncertainties remain about the use of anticoagulation for CVT in the presence of large intracerebral hemorrhages or hemorrhages located in the temporal lobe.3 The size of intracerebral hemorrhage (ICH) in CVT can range from trivial to massive. However, indication of the volume of ICH has been rare in previously published studies of CVT.3,4⇓ When CVT is treated with combined intrathrombus tissue plasminogen activator (tPA) and IV heparin, the risk of recurrent ICH is greater for patients with large ICH compared with those with small or subtle hemorrhages.4 It is not known whether treatment with IV heparin alone is associated with a similar increase in hemorrhage risk for patients with large ICH. We present a series of patients with CVT that …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
